Nationwide Children's spinoff gets FDA OK to test persistent pneumonia treatment in humans
Clarametyx Biosciences Inc. announced Wednesday that the U.S. Food and Drug Administration accepted the Columbus company's application to test the safety of its treatment for antib…
